Unavailable
Unavailable
Save time and jump to the most important pieces.
The Sanitizing Agents Market size is expected to reach 32.34 USD billion by 2029; Sanitizing Agents are a necessary sanitary product for maintaining hygiene and cleanliness in homes and environments PUNE, India, Sept. 21, 2022 /PRNewswire/ -- Sanitation has become an important aspect of the major industrial processes and commercial sectors. Sanitizing agents are being used more frequently to maintain a level of sanitation. The growing awareness of the importance of food product quality is a major reason why demand for sanitizing agents is expected to rise due to their efficiency and cost-effectiveness. Access PDF Sample Report (Including Graphs, Charts & Figures) @ https://exactitudeconsulta
NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, June 2, 2021. STERIS plc (NYSE:STE) is acquiring Cantel Medical in a deal expected to be completed soon pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector June 2, 2021 S&P MidCap 400 Addition Crocs CROX Consumer Discretionary S&P M
The EON™ Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE:CMD) business, announces the launch of the EON™ Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments. This press release
4 - CANTEL MEDICAL CORP (0000019446) (Issuer)
4 - CANTEL MEDICAL CORP (0000019446) (Issuer)
4 - CANTEL MEDICAL CORP (0000019446) (Issuer)
SC 13G - CANTEL MEDICAL LLC (0000019446) (Subject)
SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)
SC 13G/A - CANTEL MEDICAL CORP (0000019446) (Subject)
LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021. He will be taking over for Ken Serota, who will be stepping down as President effective December 31, 2020. In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel. Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team. Mr. Xilas has held various positions at Hu-Friedy with increasing responsibility over
SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)
SC TO-I/A - CANTEL MEDICAL LLC (0000019446) (Subject)
15-12B - CANTEL MEDICAL LLC (0000019446) (Filer)